Another Victory for Immune Checkpoint Blockade in Melanoma: Adjuvant Ipilimumab Over Interferon. [electronic resource]
- Journal of clinical oncology : official journal of the American Society of Clinical Oncology 02 2020
- 529-531 p. digital
Publication Type: Editorial; Comment
1527-7755
10.1200/JCO.19.02988 doi
Humans Interferon alpha-2 Ipilimumab Melanoma Nivolumab United States